Clinical Trial Update: Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening [Phase 3]

View source ↗

Summary

A Phase 3 completed trial evaluated iodine-131-labeled iodocholesterol for adrenal gland screening, sponsored by M.D. Anderson Cancer Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Gland Diseases
• Adrenal Gland Neoplasms

Drugs mentioned

• Iodine-131 Iodocholesterol (iodocholesterol)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Adrenal Gland Diseases, Adrenal Gland Neoplasms | Phase 3 | Status: COMPLETED